跳至主要内容
临床试验/NL-OMON34072
NL-OMON34072已完成不适用

Validation study: a newly developed neuropathic pain Heat-Capsaicin-Warmth (HCW) sensitization model. - Gabapentin and remifentanil HCW pain study

Top Institue Pharma0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy male volunteers, age between 18 and 40 years, caucasian race, BMI between 18 and 27 kg/m2, non or moderate smoker (<10 per day), at screening state of health must satisfy the entry requirements.

排除标准

  • Scar tissue on the anterior side of the dominant forearm, mental handicap, actual pain, history of serious allergies or allergic to gabapentin, remifentanil or capsaicin, regular/routine treatment with non-topical medications within 30 days prior to drug administration.

研究者

发起方
Top Institue Pharma

相似试验

Validation study: a newly developed neuropathic pain... | 临床试验